AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,731,413 | -12.6% | 67,698 | -10.1% | 0.04% | -21.3% |
| Q2 2023 | $5,411,919 | +750.8% | 75,312 | +630.3% | 0.05% | +683.3% |
| Q1 2023 | $636,105 | -90.2% | 10,313 | -87.8% | 0.01% | -88.9% |
| Q4 2022 | $6,506,301 | +195.2% | 84,355 | +70.8% | 0.05% | +200.0% |
| Q3 2022 | $2,204,000 | +15.9% | 49,400 | -0.5% | 0.02% | 0.0% |
| Q2 2022 | $1,901,000 | +529.5% | 49,624 | +579.8% | 0.02% | +500.0% |
| Q1 2022 | $302,000 | -91.0% | 7,300 | -92.8% | 0.00% | -91.2% |
| Q3 2021 | $3,340,000 | +2.1% | 101,317 | +154.7% | 0.03% | -22.7% |
| Q2 2020 | $3,272,000 | +341.0% | 39,772 | +215.2% | 0.04% | -6.4% |
| Q1 2020 | $742,000 | -76.2% | 12,619 | -58.2% | 0.05% | -38.2% |
| Q4 2019 | $3,120,000 | +25.9% | 30,188 | -75.4% | 0.08% | +4.1% |
| Q3 2019 | $2,479,000 | -84.2% | 122,500 | -79.9% | 0.07% | -86.8% |
| Q2 2019 | $15,702,000 | +786.6% | 609,800 | +389.8% | 0.56% | +809.8% |
| Q1 2019 | $1,771,000 | – | 124,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |